Two weeks ago, OpenAI claimed a solution to one of the biggest open problems in math —the Navier-Stokes problem, worth a million-dollar prize from the Clay Mathematics Institute. The proof ignited a ...

In what is quickly becoming an explosive controversy in mathematics, a potential solution to one of the field’s greatest open questions has been overshadowed by allegations of espionage and unethical ...

OpenAI claims one of its AI models has found a solution to the Navier-Stokes problem, one of the toughest and most enduring puzzles in mathematics, sitting on the list of Millennium Prize Problems, ...

NYU mathematics professor Tristan Buckmaster announced three proofs on Tuesday with a preliminary finding on one of the major unsolved problems in theoretical mathematics. The findings, made in ...

The company’s announcement is the most dramatic sign yet that artificial intelligence is fundamentally transforming the field of higher mathematics. By Cade Metz OpenAI said on Tuesday that its newest ...

SINGAPORE: Singapore's 15-year-olds ranked second globally in computational problem solving, a new Programme for International Student Assessment (PISA) domain that measures how students use ...

Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. This voice experience is generated by AI. Learn more. This ...

The result calls into question other late-stage trials testing Lp(a)-lowering drugs from the likes of Amgen and Eli Lilly. (iStock / Getty Images Plus) Novartis’ Ionis-partnered drug designed to lower ...

Meta’s problems just went from expensive to potentially existential as lawsuits and AI spending collide – “Not a great sign” Meta is pouring enormous sums into AI while lawsuits, legal charges and ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Many people who face a heightened ...

Elevated levels of lipoprotein(a) above 175 nmol/L is associated with increased cardiovascular risk, especially among patients with existing heart disease, and warrants aggressive treatment to reduce ...